|
2023-12-26 |
2023-12-26 |
B
Purchase
|
Non-Executive Director
|
48,563
+47.7%
455.10
US$3,199,497
|
48,563
+47.7%
|
455.10
|
US$3,199,497
|
|
|
2023-12-20 |
2023-12-20 |
B
Purchase
|
Chief Executive Officer
Executive Director
Large shareholder
|
60,458
-37.6%
268.05
US$2,299,753
|
60,458
-37.6%
|
268.05
|
US$2,299,753
|
|
|
2023-12-19 |
2023-12-19 |
B
Purchase
|
See Remarks
Officer
|
7,819
-44.6%
267.51
US$444,671
|
7,819
-44.6%
|
267.51
|
US$444,671
|
|
|
2023-12-19 |
2023-12-19 |
B
Purchase
|
Non-Executive Director
|
20,000
+108.3%
2.05
US$41,048
|
20,000
+108.3%
|
2.05
|
US$41,048
|
|
|
2023-09-13 |
2023-09-08 |
B
Purchase
|
Non-Executive Director
|
2,000
+21.9%
2.54
US$5,080
|
2,000
+21.9%
|
2.54
|
US$5,080
|
|
|
2023-03-30 |
2023-03-29 |
B
Purchase
|
Chief Executive Officer
Executive Director
Large shareholder
|
40,800
+3.0%
2.47
US$100,862
|
40,800
+3.0%
|
2.47
|
US$100,862
|
|
|
2024-01-19 |
2023-03-28 |
B
Purchase
|
Non-Executive Director
|
4,000
+26.4%
2.35
US$9,400
|
4,000
+26.4%
|
2.35
|
US$9,400
|
|
|
2023-03-29 |
2023-03-28 |
B
Purchase
|
See Remarks
Officer
|
20,000
+24.2%
2.40
US$47,970
|
20,000
+24.2%
|
2.40
|
US$47,970
|
|
|
2022-12-19 |
2022-12-19 |
B
Purchase
|
Non-Executive Director
|
3,700
+68.2%
8.33
US$30,813
|
3,700
+68.2%
|
8.33
|
US$30,813
|
|
|
2022-11-23 |
2022-11-22 |
B
Purchase
|
Non-Executive Director
|
2,000
+58.4%
8.27
US$16,540
|
2,000
+58.4%
|
8.27
|
US$16,540
|
|
|
2022-09-15 |
2022-09-13 |
B
Purchase
|
Non-Executive Director
|
1,000
+50.0%
8.20
US$8,200
|
1,000
+50.0%
|
8.20
|
US$8,200
|
|
|
2022-09-15 |
2022-09-12 |
B
Purchase
|
Non-Executive Director
|
2,000
+inf%
8.85
US$17,700
|
2,000
+inf%
|
8.85
|
US$17,700
|
|
|
2022-08-15 |
2022-08-12 |
B
Purchase
|
Chief Executive Officer
Executive Director
Large shareholder
|
26,350
+1.9%
7.84
US$206,600
|
26,350
+1.9%
|
7.84
|
US$206,600
|
|
|
2022-06-23 |
2022-06-22 |
PP
Planned purchase
|
Chief Executive Officer
Executive Director
Large shareholder
|
40,308
+3.0%
2.91
US$117,296
|
40,308
+3.0%
|
2.91
|
US$117,296
|
|
|
2022-06-23 |
2022-06-21 |
PP
Planned purchase
|
Chief Executive Officer
Executive Director
Large shareholder
|
29,082
+2.2%
2.79
US$81,040
|
29,082
+2.2%
|
2.79
|
US$81,040
|
|
|
2022-06-09 |
2022-06-09 |
B
Purchase
|
See Remarks
Officer
|
10,000
+15.5%
2.97
US$29,720
|
10,000
+15.5%
|
2.97
|
US$29,720
|
|
|
2022-06-09 |
2022-06-08 |
B
Purchase
|
See Remarks
Officer
|
25,848
+66.8%
3.02
US$78,188
|
25,848
+66.8%
|
3.02
|
US$78,188
|
|
|
2022-06-09 |
2022-06-07 |
B
Purchase
|
See Remarks
Officer
|
14,152
+57.7%
3.04
US$43,007
|
14,152
+57.7%
|
3.04
|
US$43,007
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
President
Executive Director
|
59
-0.0%
22.47
US$1,326
|
59
-0.0%
|
22.47
|
US$1,326
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
President
Executive Director
|
2,925
-0.8%
21.74
US$63,592
|
2,925
-0.8%
|
21.74
|
US$63,592
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
Chief Medical Officer
Officer
|
16
-0.0%
22.47
US$360
|
16
-0.0%
|
22.47
|
US$360
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
Chief Medical Officer
Officer
|
804
-0.9%
21.74
US$17,480
|
804
-0.9%
|
21.74
|
US$17,480
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
See Remarks
Officer
|
4
-0.0%
22.47
US$90
|
4
-0.0%
|
22.47
|
US$90
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
See Remarks
Officer
|
196
-0.8%
21.74
US$4,261
|
196
-0.8%
|
21.74
|
US$4,261
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
Chief Financial Officer
Officer
|
29
-0.0%
22.47
US$652
|
29
-0.0%
|
22.47
|
US$652
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
Chief Financial Officer
Officer
|
1,405
-1.0%
21.74
US$30,546
|
1,405
-1.0%
|
21.74
|
US$30,546
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
96
-0.0%
22.47
US$2,157
|
96
-0.0%
|
22.47
|
US$2,157
|
|
|
2021-12-07 |
2021-12-02 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
4,715
-0.4%
21.74
US$102,509
|
4,715
-0.4%
|
21.74
|
US$102,509
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
President
Executive Director
|
76
-0.0%
24.22
US$1,841
|
76
-0.0%
|
24.22
|
US$1,841
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
President
Executive Director
|
350
-0.1%
23.27
US$8,143
|
350
-0.1%
|
23.27
|
US$8,143
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
President
Executive Director
|
202
-0.1%
22.19
US$4,482
|
202
-0.1%
|
22.19
|
US$4,482
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Medical Officer
Officer
|
21
-0.0%
24.22
US$509
|
21
-0.0%
|
24.22
|
US$509
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Medical Officer
Officer
|
96
-0.1%
23.27
US$2,234
|
96
-0.1%
|
23.27
|
US$2,234
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Medical Officer
Officer
|
56
-0.1%
22.19
US$1,242
|
56
-0.1%
|
22.19
|
US$1,242
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
See Remarks
Officer
|
123
-0.5%
24.22
US$2,980
|
123
-0.5%
|
24.22
|
US$2,980
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
See Remarks
Officer
|
563
-2.2%
23.27
US$13,099
|
563
-2.2%
|
23.27
|
US$13,099
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
See Remarks
Officer
|
325
-1.2%
22.19
US$7,210
|
325
-1.2%
|
22.19
|
US$7,210
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Financial Officer
Officer
|
880
-0.6%
24.22
US$21,317
|
880
-0.6%
|
24.22
|
US$21,317
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Financial Officer
Officer
|
4,034
-2.9%
23.27
US$93,855
|
4,034
-2.9%
|
23.27
|
US$93,855
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Financial Officer
Officer
|
2,332
-1.6%
22.19
US$51,738
|
2,332
-1.6%
|
22.19
|
US$51,738
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
2,953
-0.2%
24.22
US$71,533
|
2,953
-0.2%
|
24.22
|
US$71,533
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
13,539
-1.0%
23.27
US$314,998
|
13,539
-1.0%
|
23.27
|
US$314,998
|
|
|
2021-12-07 |
2021-12-01 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
7,829
-0.6%
22.19
US$173,694
|
7,829
-0.6%
|
22.19
|
US$173,694
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
President
Executive Director
|
74
-0.0%
25.38
US$1,878
|
74
-0.0%
|
25.38
|
US$1,878
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
President
Executive Director
|
210
-0.1%
24.68
US$5,182
|
210
-0.1%
|
24.68
|
US$5,182
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
President
Executive Director
|
194
-0.1%
24.00
US$4,655
|
194
-0.1%
|
24.00
|
US$4,655
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Medical Officer
Officer
|
20
-0.0%
25.38
US$508
|
20
-0.0%
|
25.38
|
US$508
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Medical Officer
Officer
|
58
-0.1%
24.68
US$1,431
|
58
-0.1%
|
24.68
|
US$1,431
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Medical Officer
Officer
|
53
-0.1%
24.00
US$1,272
|
53
-0.1%
|
24.00
|
US$1,272
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
See Remarks
Officer
|
118
-0.4%
25.38
US$2,995
|
118
-0.4%
|
25.38
|
US$2,995
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
See Remarks
Officer
|
338
-1.3%
24.68
US$8,340
|
338
-1.3%
|
24.68
|
US$8,340
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
See Remarks
Officer
|
312
-1.1%
24.00
US$7,487
|
312
-1.1%
|
24.00
|
US$7,487
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Financial Officer
Officer
|
848
-0.6%
25.38
US$21,521
|
848
-0.6%
|
25.38
|
US$21,521
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Financial Officer
Officer
|
2,422
-1.7%
24.68
US$59,765
|
2,422
-1.7%
|
24.68
|
US$59,765
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Financial Officer
Officer
|
2,240
-1.5%
24.00
US$53,753
|
2,240
-1.5%
|
24.00
|
US$53,753
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
2,845
-0.2%
25.38
US$72,203
|
2,845
-0.2%
|
25.38
|
US$72,203
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
8,126
-0.6%
24.68
US$200,517
|
8,126
-0.6%
|
24.68
|
US$200,517
|
|
|
2021-12-07 |
2021-11-30 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
7,519
-0.5%
24.00
US$180,433
|
7,519
-0.5%
|
24.00
|
US$180,433
|
|
|
2021-12-06 |
2021-11-29 |
S
Sale
|
Chief Financial Officer
Officer
|
4,599
-3.0%
23.89
US$109,870
|
4,599
-3.0%
|
23.89
|
US$109,870
|
|
|
2021-12-06 |
2021-11-29 |
S
Sale
|
See Remarks
Officer
|
642
-2.3%
23.89
US$15,337
|
642
-2.3%
|
23.89
|
US$15,337
|
|
|
2021-12-06 |
2021-11-29 |
S
Sale
|
Chief Medical Officer
Officer
|
110
-0.1%
23.89
US$2,628
|
110
-0.1%
|
23.89
|
US$2,628
|
|
|
2021-12-06 |
2021-11-29 |
S
Sale
|
President
Executive Director
|
399
-0.1%
23.89
US$9,532
|
399
-0.1%
|
23.89
|
US$9,532
|
|
|
2021-12-06 |
2021-11-29 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
15,435
-1.1%
23.89
US$368,742
|
15,435
-1.1%
|
23.89
|
US$368,742
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Medical Officer
Officer
|
37
-0.0%
25.77
US$954
|
37
-0.0%
|
25.77
|
US$954
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Medical Officer
Officer
|
44
-0.0%
25.00
US$1,100
|
44
-0.0%
|
25.00
|
US$1,100
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Medical Officer
Officer
|
48
-0.1%
24.05
US$1,155
|
48
-0.1%
|
24.05
|
US$1,155
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
See Remarks
Officer
|
214
-0.8%
25.77
US$5,515
|
214
-0.8%
|
25.77
|
US$5,515
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
See Remarks
Officer
|
258
-0.9%
25.00
US$6,450
|
258
-0.9%
|
25.00
|
US$6,450
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
See Remarks
Officer
|
278
-1.0%
24.05
US$6,687
|
278
-1.0%
|
24.05
|
US$6,687
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Financial Officer
Officer
|
1,124
-0.7%
25.77
US$28,967
|
1,124
-0.7%
|
25.77
|
US$28,967
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Financial Officer
Officer
|
1,354
-0.9%
25.00
US$33,849
|
1,354
-0.9%
|
25.00
|
US$33,849
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Financial Officer
Officer
|
1,459
-0.9%
24.05
US$35,093
|
1,459
-0.9%
|
24.05
|
US$35,093
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
4,859
-0.3%
25.77
US$125,221
|
4,859
-0.3%
|
25.77
|
US$125,221
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
5,852
-0.4%
25.00
US$146,294
|
5,852
-0.4%
|
25.00
|
US$146,294
|
|
|
2021-11-30 |
2021-11-24 |
S
Sale
|
Chief Executive Officer
Executive Director
Large shareholder
|
6,311
-0.5%
24.05
US$151,798
|
6,311
-0.5%
|
24.05
|
US$151,798
|
|